Description
This combination provides two mechanistically complementary growth hormone secretagogue peptides in a single research set. Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that binds the GHRH receptor on pituitary somatotrophs, stimulating pulsatile GH release while mirroring the physiological activity of endogenous GHRH. Ipamorelin is a selective, third-generation growth hormone secretagogue and ghrelin receptor (GHSR-1a) agonist known for its high GH specificity with minimal off-target stimulation of ACTH, cortisol, or prolactin — a property that makes it a favored tool peptide for mechanistic axis studies. Together they engage distinct receptor pathways converging on GH release, enabling research designs that probe GHRH-GHS synergy, pituitary responsiveness, IGF-1 downstream signaling, and the differential pharmacology of GHRH-R versus GHSR-1a.
Both peptides are supplied as individually sealed lyophilized vials of research-grade purity, suitable for reconstitution in sterile aqueous vehicles for cell-based pituitary assays, rodent GH secretion models, and comparative pharmacokinetic studies. Storage at -20 degrees Celsius is recommended. Researchers should reconstitute each vial separately per validated protocols for the intended experimental system. For laboratory research use only. Not for human or veterinary use.





Reviews
There are no reviews yet.